Upcoming Events
Log In
Pricing
Free Trial

Wk 5, Case 1 - Review

HIDE
PrevNext

0:00

So this first one was a case of radiation changes following

0:05

treatment for radiation therapy. I believe this section was on larynx,

0:10

I believe, if I, if I recall. Mm-hmm. So, um,

0:13

this first case was an example of a patient that had an early true vocal cord

0:17

carcinoma. It's hard to see actually on the pre-treatment study,

0:21

but when we look at the post-treatment study,

0:23

what we end up seeing is diffuse thickening involving

0:28

the, uh,

0:29

true vocal cords and diffuse thickening involving the bilateral area

0:34

epiglottic fos.

0:35

So one thing that's a little bit unusual is because it's a left true vocal cord

0:40

carcinoma,

0:40

they gave a little bit more radiation therapy on the left than on the right. Um,

0:46

the, the attenuation here is actually low attenuation,

0:49

so there's really no aggressive mass seen. Um,

0:53

obviously you can't di differentiate between recurrent tumor,

0:58

uh, microscopic recurrent tumor and just post-treatment changes.

1:02

So I think if you did say you should always in your report say you can't exclude

1:06

microscopic disease, but these findings are pretty much consistent with,

1:11

um, post-treatment changes. So,

1:15

you know what I wanted to do and um, lemme see if I could bring this up here.

1:20

So following radiation therapy,

1:23

what ends up happening is that the radiation therapy elicits an acute

1:27

inflammatory response and this lasts typically about 24 hours.

1:31

And this is followed by interstitial edema. So after you give radiation therapy,

1:35

there's a lot of edema. There's also disruption in the blood vessels, um,

1:40

and the lymphatics.

1:42

And in approximately four weeks you end up developing fibrosis and this involves

1:46

the connective tissues, the blood vessels, and the lymphatics.

1:49

And oftentimes patients are treated with radiation therapy and chemotherapy.

1:54

So what the chemotherapy does is just, it just sort of exacerbates the changes.

1:59

So on the left here is a pre-treatment image and on the right here is

2:02

post-treatment.

2:04

And you can see after post-treatment you can see skin thickening.

2:07

We can see thickening of the platysma muscle,

2:10

we can see thickening here of the strap muscles.

2:13

Notice the radiation changes and thickening involved in the submandibular

2:17

glands. Here's one area epiglottic fold. Here's the other area. Epiglottic fold.

2:21

See how they're diffusely thickened in their symmetric bilaterally.

2:24

And we can see thickening of the posterior pharyngeal wall and we can see edema

2:28

involving the retro pharyngeal space. Another example here,

2:33

pre-treatment, we can see the free margin of the epiglottis.

2:36

After we give radiation therapy,

2:38

we can see diffuse thickening of the epiglottis and notice a low attenuation

2:42

here. There's low attenuation here and that's more indicative of post-treatment

2:45

changes. Also, look at the submandibular glands.

2:48

We can see that they're thickened, or excuse me,

2:51

they're actually in this case shrunken.

2:53

We can see skin thickening here and reticulation of the subcutaneous fat.

2:57

And look at the thickening of the patal muscle two and compare that to the

3:01

pre-treatment studies. Again,

3:05

pre-treatment versus post-treatment.

3:07

These are those changes that you expect to see.

3:09

We see the diffuse skin thickening, we can see the low attenuation.

3:12

And one of the key things that we look for is, uh, sym symmetry.

3:18

Now what about response? So here's example of what we would like to see.

3:22

So here is a pre-treatment image, a large mass here,

3:25

and we can see complete results after radiation therapy.

3:29

Another example here, d uh,

3:31

large mass here involving the left vem after radiation therapy.

3:35

Look at all the changes here. Diffuse thickening of the free margin,

3:38

the epiglottic colotti thickening of the median gloss of epiglottic fold.

3:44

We can see the radiation sil adenitis, uh,

3:47

characterized by decrease in size of the submandibular glands and,

3:51

and abnormal enhancement.

3:53

So the things that we look for after radiation therapy is that what we would

3:58

like to see is a situation like this where we have a mass on the right side and

4:02

after radiation therapy we see complete resolution.

4:05

See how it's completely shrunk. In this particular case, pre-treatment,

4:09

post-treatment, we still see this persistent mass.

4:12

So what we look for is that another example here,

4:16

this is an example of pre-treatment and after treatment we can still see this

4:21

residual focal enhancing mass. So the way the,

4:24

what we would like to see is either complete resolution such as this

4:29

and it completely vanished.

4:31

Or what we end up looking for is a persistent soft tissue mass in which

4:36

the tumor has not reduced by greater than 50%.

4:40

So those are the things that we look for, um, uh, in order to look to,

4:45

to look at complete response. I think the challenge, um,

4:48

in this case was, uh, because there was a left sided tumor,

4:53

a lot of the patients now are getting higher doses to the side of the tumor.

4:57

So we do see the typical changes where we see the low attenuation.

5:00

It's a little bit thicker on the left than on the right,

5:03

but in general we don't see a, a bulky mass here.

5:06

Rather we see all these changes that we would typically expect to see after

5:10

radiation therapy.

5:12

So let me stop there and do you have any questions at all for that?

5:15

So actually, if we don't have any previous image, we have to look for any,

5:21

if any obvious enhancement, you'll be the recurrence or residue disease.

5:26

If not, if we see any low ation will be just edema for the radiation.

5:32

Yeah, it's more indicative.

5:33

So specifically what we look for is an enlarging mass at the primary site or

5:37

along the margin. So that's the one thing that we look for. And, and,

5:41

and enlarging, if we see a big mass pre-treatment,

5:44

we want to see if that mass completely resolves.

5:47

If there is a lower volume lesion and then after radiation therapy the mass

5:51

starts to up, there's a, a, a mass that's growing at the site of the treatment,

5:57

then that's more that's indicative of recurrent tumor.

6:00

The other thing that we always have to look for too is we also want to evaluate

6:04

the lymph nodes because sometimes you'll see nothing at the

6:08

primary site. But then once we look, uh, more in the neck,

6:13

sometimes we'll have recurrences involving the the, um,

6:17

we will have nodal metastases.

Report

Patient History
T1 left true vocal cord carcinoma treated with definitive radiation therapy. Laryngeal pain.
Findings
Contrast-enhanced CT was performed from the skull base to the thoracic inlet. Patient has history of left T1 true vocal cord carcinoma treated with definitive radiation therapy. The study demonstrates diffuse enlargement of the bilateral aryepiglottic folds with the left being larger than the right. The attenuation within the aryepiglottic folds is relatively symmetric and relatively decreased attenuation indicating posttreatment edematous changes. No obvious evidence of aggressive masses is identified. The CT scan was obtained with breath holding which results in apposition of the true vocal cords which prevents detailed evaluation of the anterior and posterior commissures.

Bone windows show no evidence of cartilage erosion. No evidence of abnormal soft tissue air.

No evidence of enlarged lymph nodes are identified using standard size criteria.

The visualized portion of the lungs is grossly within normal limits, however, dedicated chest CT is necessary for complete diagnostic evaluation.

Visualization of the brain is grossly within normal limits. However, dedicated brain imaging is necessary for complete diagnostic evaluation.

Conclusions
1. Findings consistent with posttreatment changes following radiation therapy with asymmetry involving the left aryepiglottic fold likely due to higher dose delivery.
2. No evidence of enlarged lymph nodes using standard size criteria.

Case Discussion

Faculty

David M Yousem, MD, MBA

Professor of Radiology, Vice Chairman and Associate Dean

Johns Hopkins University

Suresh K Mukherji, MD, FACR, MBA

Clinical Professor, University of Illinois & Rutgers University. Faculty, Michigan State University. Director Head & Neck Radiology, ProScan Imaging

Tags

Neuroradiology

Head and Neck

CT